SQUAMOUS CELL in Croatian translation

• planocelularni
• pločastih stanica
• skvamoznih stanica
• pločaste stanice
• squamous cell
• skvamoznim
• planocelularnog

Examples of using Squamous cell in English and their translations into Croatian

Cutaneous squamous cell carcinomas are typically fast growing tumors that get bigger with time
Kožni karcinomi pločastih stanica se obično brzo rastu tumora da biste dobili veći s vremenom

A squamous cell carcinoma of the lung is a type of metastasizing tumor that arises from the squamous epithelium in lungs.
Planocelularni karcinom pluća je vrsta metastaza tumora koji proizlazi iz pločastog epitela u plućima.

As with other types of squamous cell carcinomas, middle-aged
Kao i kod drugih vrsta pločastih stanica karcinoma, sredovječni

A squamous cell carcinoma of the tonsils is an aggressive
Planocelularni karcinom krajnika je agresivna

including basal cell, squamous cell, and Merkel cell carcinoma,
uključujući karcinom bazalnih stanica, skvamoznih stanica i Merkelovih stanica,

The squamous cell carcinoma is followed by the incidence of malignant skin diseases, most often happening on the lips,
Planocelularni karcinom(squamous cell carcinoma) je slijedeći po učestalosti malignih oboljenja kože, najčešće se sreće na usnama,

such as squamous cell carcinoma, while others,
su karcinom pločastih stanica, dok drugi, kao što su adenokarcinom,

Voriconazole Accord should be discontinued if premalignant skin lesions or squamous cell carcinoma are identified.
Voriconazole Accord treba prekinuti ako se uoče predmaligne lezije kože ili karcinom skvamoznih stanica.

Bowen's disease- a rare skin disease is dangerous because it goes untreated into squamous cell carcinoma.
Bowen bolest- retka bolest kože je opasno, jer to ide netretiranih u planocelularni karcinom.

A lower incidence of squamous cell carcinoma of the skin was observed in the sirolimus group 0% vs.
Niža incidencija karcinoma pločastih stanica kože uočena je u skupini koja je primala sirolimus 0% naspram 4.

Dose modifications are not recommended for adverse reactions of cutaneous squamous cell carcinoma(cuSCC) or new primary melanoma see dabrafenib SmPC for further details.
Prilagodbe doze ne preporučuje se kod nuspojava u obliku planocelularnog karcinoma kože(eng. cutaneous squamous cell carcinoma, cuSCC) ili novog primarnog melanoma vidjeti Sažetak opisa svojstava lijeka za dabrafenib za dodatne pojedinosti.

A statistically significant increased incidence of squamous cell carcinoma of the clitoral gland was observed at that dose.
Pri toj dozi opažena je statistički značajno povećana incidencija karcinoma skvamoznih stanica klitoralne žlijezde.

Organ transplant patients have an increased risk of developing squamous cell carcinoma mainly because of immunosuppression.
Pacijenti s transplantiranim organom imaju povecan rizik od razvoja planocelularnog karcinoma zbog imunosupresivne terapije i posljedicne imunosupresije.

In patients with locally advanced squamous cell cancer of the head
Kod bolesnika s lokalno uznapredovalim karcinomom pločastih stanica glave i vrata,

Up to 3 in 100 people taking Mekinist in combination with dabrafenib may develop a different type of skin cancer called cutaneous squamous cell carcinoma cuSCC.
U do 3 na 100 osoba koje uzimaju Mekinist u kombinaciji s dabrafenibom može se razviti drugačija vrsta raka kože koji se naziva planocelularni karcinom kože eng. cutaneous squamous cell carcinoma, cuSCC.

In vitro, bexarotene inhibits the growth of tumour cell lines of haematopoietic and squamous cell origin.
In vitro, beksaroten inhibira rast tumorskih staničnih linija koje potječu od hematopoetskih i skvamoznih stanica.

on the account of a decrease in the incidence of squamous cell carcinoma of the lung has been confirmed.
izravnoj vezi s pušenjem, na račun pada broja učestalosti planocelularnog raka pluća.

lichen planus and squamous cell carcinoma is low
lichen planusu i karcinomu pločastih stanica niska je

Dose modifications or interruptions are not recommended for adverse reactions of cutaneous squamous cell carcinoma(cuSCC) or new primary melanoma see section 4.4.
Prilagođavanje doze ili privremeni prekid terapije ne preporučuju se kod nuspojava u obliku planocelularnog karcinoma kože(engl. cutaneous squamous cell carcinoma(cuSCC)) ili novonastalog primarnog melanoma vidjeti dio 4.4.

The only variables that showed statistically significant correlations with bleeding were Avastin therapy and squamous cell histology.
Jedine varijable koje su pokazale statistički značajne korelacije s krvarenjem jesu terapija lijekom Avastin i histologija skvamoznih stanica.